M-A: SGLT-2 inhibitors and cardiovascular outcomes in patients with and without a history of heart failure.

SGLT-2 inhibitors and cardiovascular outcomes in patients with and without a history of heart failure: a systematic review and meta-analysis – European Heart Journal – Cardiovascular Pharmacotherapy

Commentary on Twitter

SGLT-2 inhibitors improve CV outcomes irrespective of heart failure history and LVEF: a meta-analysis of RCTs https://t.co/QPRCzT9olH#EHJPharmacotherapy #cardiotwitter @AgewallStefan @GianluSava pic.twitter.com/sESFn7Fdxg

— European Society of Cardiology Journals (@ESC_Journals) January 29, 2022